With limited treatment options for stroke patients available, two UConn researchers are developing an experimental drug that is capable of protecting the brain and improving recovery after a cerebral vascular accident also known as a brain attack.

Rajkumar Verma, assistant professor at UConn Health who leads a research program for advancing innovative therapies for stroke, and Raham Bahal, associate professor in the Department of Pharmaceutical sciences at UConn, targeted a small regulatory biological molecule called microRNA, which becomes abnormally elevated after stroke and promotes inflammation, contributes to tissue loss and causes a decline in neurological function, the researchers told the Courant.

MicroRNAs (miRNAs) are a class of non-coding RNAs, which do not translate into pr

See Full Page